315 Evening Gala Exposes the Scam of the Universal Panacea

"Exosomes have been very popular in the anti-aging industry in recent years." This is an introduction to a type of product that is currently hot in the medical beauty market. According to reports from various medical publications and industry insiders, exosomes, the miraculous substance promoted by influencers, are actually bioactive substances secreted during the cultivation of stem cells. However, the mechanism of action, clinical testing, and other medical procedures related to this substance in the medical and academic fields are still not clear, and most of the information is still in the stage of academic and theoretical research. According to research, in June 2025, the National Medical Products Administration's Drug Evaluation Center released a draft for soliciting opinions, which includes exosomes that have therapeutic functions and rely on active ingredients to be regulated as drugs. However, this is just a draft for soliciting opinions. The purpose is to control the entry of such substances into society in order to prevent abuse or misuse. As of now, no exosome drugs in China have received approval for marketing and sales. To understand the specific situation, a reporter from a TV program conducted an investigation based on information provided by consumers and found a product called "Qingcheng," which contains exosomes on the market. The staff of the manufacturer, Haolin Biotechnology Co., Ltd., told the reporter that the main ingredient in their product is exosomes, but in order to avoid market supervision, they obtained a license for collagen. Besides using false licenses, illegal additives, and illegal sales, this is not the full extent of the chaos surrounding exosomes. Some companies in the market are engaged in false advertising, claiming that their exosome products can not only be used for beauty and anti-aging purposes but can even treat various diseases. In a bioengineering company in a southwestern city, the company's leader, Mr. Tan, openly admitted to reporters that they use exosomes to treat diseases. According to Mr. Tan, diseases such as epilepsy, arthritis, and diabetes can be resolved by introducing exosomes. Seeing the skeptical expressions of the reporters, Mr. Tan took out what he claimed was medical-grade exosome frozen solution from the refrigerator for demonstration. There was no product information on the packaging, indicating it was a "three no" product. Mr. Tan also mentioned that because his company does not have medical qualifications, the injection of exosomes can only be done in collaboration with medical institutions, which in the industry is referred to as "borrowing a platform to administer injections." In this way, without national approval, without passing any clinical trials, and without any efficacy data, these so-called "exosomes" are being packaged by these companies as a "cure-all" miracle drug and even being injected into the bodies of patients through the method of "borrowing a platform to administer injections." This business is quite profitable. Mr. Tan explained, "The first time costs 15 billion, the second time 20 billion, the third time 25 billion. Gradually, a total of 60 billion is used, and we charge 60,000 yuan."